Biography
Mr. Siegel is assistant general counsel at Ipsen Biopharmaceuticals and supports businesses in each of Ipsen’s therapeutic areas, including oncology, neuroscience, and rare diseases. He advises colleagues in a variety of functions, including advertising and promotion, incentive compensation, patient advocacy, patient support programs, corporate communications, and internal investigations. In the latter capacity, he regularly counsels on issues related to the False Claims Act, the Anti-Kickback Statute, the Beneficiary Inducement Statute, the Lanham Act, and the Federal Food, Drug, and Cosmetic Act, among other statutes. Before transitioning to an in-house role, Mr. Siegel spent several years at a leading Boston law firm, where he worked with a variety of companies and individuals in the biopharmaceutical space.
Bio last updated in September 2022.